Skip to main content

Advertisement

Log in

Clinical Response to Thyroidectomy in Three Cases of Refractory Hashimoto’s Encephalopathy—a Potential Therapy

  • Original Article
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

Hashimoto’s thyroiditis is a common endocrine disorder. Clinical presentation in Hashimoto’s thyroiditis is predominantly due to associated hypothyroidism with or without goiter-related neck complaints. Rarely, HT can be associated with recurrent encephalopathy characterized by seizures, amnesia, and comatose episodes. The treatment for this enigmatic disease is symptomatic and supportive with no curative option. There are meager, anecdotal reports on the role of thyroidectomy as a treatment option. In this context, we report our experience on impact of total thyroidectomy on Hashimoto’s encephalopathy, refractory to anti-epileptic medications and steroids. This is a retrospective study conducted in an endocrine surgery department of a tertiary care hospital. Three patients with Hashimoto’s encephalopathy are included in this study. All the clinico-investigative and operative data are scrutinized and analyzed. All of them underwent uneventful total thyroidectomy. Written informed consent was obtained in all cases. Mean follow-up after surgery was 1.6 SD 0.8 years (1.2–2.8). Mean age was 46 ± 6.4 years (39–52). None of the patients had associated hypertension, migraine, diabetes, or any other neurological illnesses. The mean preoperative serum anti-thyroperoxidase antibody level was 445 SD 106.2 IU/L (370–700), which was above the upper reference limit of 60 IU/L and post-operative level was 62.75 SD 34 IU/L (32–104). There was complete remission of seizure attacks in all the cases till the last follow-up period. Total thyroidectomy appears to be a viable curative option for refractory Hashimoto’s encephalopathy. Anti-thyroperoxidase antibody-related autoimmunity appears to play a role in Hashimoto’s encephalopathy etiologic cascade. Long-term impact and multi-institutional results are required to validate the curative role of surgery in this condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. World Medical Organization (2004) Declaration of Helsinki. BM J 313:1448–1449

    Google Scholar 

  2. Tunbridge WM, Vanderpump MP (2000) Population screening for autoimmune thyroid disease. Endocrinol Metab Clin N Am 29:239–253

    Article  CAS  Google Scholar 

  3. Hegedus L, Hansen JM, Feldt-Rasmussen U (1991) Influence of thyroxine treatment on thyroid size and antithyroid peroxidase antibodies in Hashimoto’s thyroiditis. Clin Endocrinol 35:235–238

    Article  CAS  Google Scholar 

  4. Bhargav PR, Shekhar S (2011) Surgical indications for goiter with background Hashimoto’s thyroiditis: institutional experience. Indian J Surg 73:414–418

    Article  CAS  Google Scholar 

  5. Shih ML, Lee JA, Hsieh CB, Yu JC, Liu HD, Kebebew E, Clark OH, Duh QY (2008) Thyroidectomy for Hashimoto’s thyroiditis: complications and associated cancers. Thyroid 18:729–734

    Article  Google Scholar 

  6. Kochupillai N (2000) Clinical endocrinology in India. Curr Sci 79:1061–1067

    Google Scholar 

  7. Ferracci F, Moretto G, Candeago RM, Cimini N, Conte F, Gentile M, Papa N, Carnevale A (2003) Antithyroid antibodies in the CSF: their role in the pathogenesis of Hashimoto’s encephalopathy. Neurology 60:712–714

    Article  CAS  Google Scholar 

  8. Ferracci F, Carnevale A (2006) The neurological disorder associated with thyroid autoimmunity. J Neurol 253:975–984

    Article  CAS  Google Scholar 

  9. Henchey R, Cibula J, Helveston W, Malone J, Gilmore R (1995) Electro-encephalographic findings in Hashimoto’s encephalopathy. Neurology 45:977–981

    Article  CAS  Google Scholar 

  10. Watemberg N, Greenstein D, Levine A (2006) Encephalopathy associated with Hashimoto thyroiditis: pediatric perspective. J Child Neurol 21:1–5

    Article  Google Scholar 

  11. Barker R, Zajicek J, Wilkinson I (1996) Thyrotoxic Hashimoto’s encephalopathy. J Neurol Neurosurg Psychiatry 60:234

    Article  CAS  Google Scholar 

  12. Asher R (1949) Myxoedematous madness. Br Med J 2:555–562

    Article  CAS  Google Scholar 

  13. Cantón A, de Fàbregas O, Tintoré M, Mesa J, Codina A, Simó R (2000) Encephalopathy associated to autoimmune thyroid disease: a more appropriate term for an underestimated condition? J Neurol Sci 176:65–66

    Article  Google Scholar 

  14. Rodriguez AJ, Jicha GA, Steeves TD, Benarroch EE, Westmoreland BF (2006) EEG changes in a patient with steroid-responsive encephalopathy associated with antibodies to thyroperoxidase (SREAT, Hashimoto’s encephalopathy). J Clin Neurophysiol 23:371–373

    Article  Google Scholar 

  15. Peschen-Rosin R, Schabet M, Dichgans J (1999) Manifestation of Hashimoto’s encephalopathy years before onset of thyroid disease. Eur Neurol 41:79–84

    Article  CAS  Google Scholar 

  16. Katoh N, Yoshida T, Shimojima Y, Gono T, Matsuda M, Yoneda M, Ikeda SI (2007) An 85-year-old case with Hashimoto’s encephalopathy, showing spontaneous complete remission. Intern Med 46:1613–1616

    Article  Google Scholar 

  17. Gini B, Lovato L, Cianti R, Cecotti L, Marconi S, Anghileri E, Armini A, Moretto G, Bini L, Ferracci F, Bonetti B (2008) Novel autoantigens recognized by CSF IgG from Hashimoto’s encephalitis revealed by a proteomic approach. J Neuroimmunol 196:153–158

    Article  CAS  Google Scholar 

  18. Zettinig G, Asenbaum S, Fueger BJ, Hofmann A, Diemling M, Mittlboeck M, Dudczak R (2003) Increased prevalence of sublinical brain perfusion abnormalities in patients with autoimmune thyroiditis: evidence of Hashimoto’s encephalitis? Clin Endocrinol 59:637–643

    Article  Google Scholar 

  19. Chen N, Qin W, Wei C, Wang X, Li K (2011) Time course of Hashimoto’s encephalopathy revealed by MRI: report of two cases. J Neurol Sci 300:169–172

    Article  Google Scholar 

  20. Allam H, Kassar D, Chand P, Iyadurai S (2013) Treatment of refractory Hashimoto’s encephalitis by thyroidectomy. Neurology 80(7S)

  21. Yuceyar N, Karadeniz M, Erdogan M, Copur A, Akgun A, Kumral E, Ozgen G (2007) Thyrotoxic autoimmune encephalopathy in a female patient: only partial response to typical immunosuppressant treatment and remission after thyroidectomy. Clin Neurol Neurosurg 109:458–462

    Article  Google Scholar 

  22. Chen C, Chand P, Iyadurai S, Scaduto M, Vavares M (2013) Mixed clinical response after total thyroidectomy in two patients with Hashimoto’s encephalopathy. Thyroid Disorders Ther 2:131. https://doi.org/10.4172/2167-7948.1000131

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ramakanth Bhargav Panchangam.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Panchangam, R.B., Kota, S.K. & Mayilvaganan, S. Clinical Response to Thyroidectomy in Three Cases of Refractory Hashimoto’s Encephalopathy—a Potential Therapy. Indian J Surg 83, 708–711 (2021). https://doi.org/10.1007/s12262-020-02476-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-020-02476-5

Keywords

Navigation